Actemra 160mg, a medication known scientifically as tocilizumab, represents a potent therapeutical agent primarily employed for the management of rheumatoid arthritis. This powerful substance operates by inhibiting the activity of interleukin-6 (IL-6), a regulatory protein crucial in the inflammatory process. Furthermore, Actemra has shown promise